汇宇制药-W
(688553)
| 流通市值：54.65亿 | | | 总市值：67.41亿 |
| 流通股本：5.07亿 | | | 总股本：6.26亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,539,504,416.6 | 2,461,388,202.46 | 2,403,464,615.88 | 2,284,936,992.77 |
| 交易性金融资产 | 239,655,214.3 | 300,734,787.88 | 278,427,742.45 | 323,672,181.61 |
| 应收票据及应收账款 | 140,130,656.38 | 85,300,784.85 | 92,330,545.98 | 80,059,323.63 |
| 其中：应收票据 | 1,151,400 | 1,113,895.85 | - | - |
| 应收账款 | 138,979,256.38 | 84,186,889 | 92,330,545.98 | 80,059,323.63 |
| 预付款项 | 43,733,462.95 | 48,502,261.93 | 23,501,458.62 | 54,170,088.55 |
| 其他应收款合计 | 4,154,759.44 | 3,791,536.27 | 2,332,351.91 | 4,276,814.7 |
| 存货 | 305,756,924.85 | 281,260,212.25 | 263,754,450.95 | 236,197,846.62 |
| 其他流动资产 | 106,237,535.22 | 119,041,759.16 | 108,836,604.76 | 93,039,595.6 |
| 流动资产合计 | 3,379,172,969.74 | 3,300,019,544.8 | 3,172,647,770.55 | 3,076,352,843.48 |
| 非流动资产: | | | | |
| 长期股权投资 | 89,609,555.91 | 89,053,538.12 | 89,053,538.12 | 89,990,832.7 |
| 其他非流动金融资产 | 79,799,002.23 | 75,128,880.39 | 85,842,482.78 | 62,432,882.93 |
| 固定资产 | 1,015,383,727.35 | 1,039,636,832.65 | 1,058,707,612.04 | 929,527,909.91 |
| 在建工程 | 422,576,753.57 | 418,950,416.25 | 414,468,666.22 | 513,786,198.1 |
| 无形资产 | 57,301,953.79 | 58,398,426.38 | 58,409,773.35 | 60,365,087.95 |
| 开发支出 | 79,658,099.58 | 72,483,204.18 | 67,439,825.15 | 52,794,643.32 |
| 长期待摊费用 | - | - | 153,627.21 | 384,068.13 |
| 递延所得税资产 | 66,548,710.03 | 63,046,205.8 | 60,512,859.11 | 47,702,283.29 |
| 其他非流动资产 | 14,272,537.33 | 11,855,274.5 | 12,263,273.41 | 42,900,900.83 |
| 非流动资产合计 | 1,825,150,339.79 | 1,828,552,778.27 | 1,846,851,657.39 | 1,799,884,807.16 |
| 资产总计 | 5,204,323,309.53 | 5,128,572,323.07 | 5,019,499,427.94 | 4,876,237,650.64 |
| 流动负债: | | | | |
| 短期借款 | 707,188,043.89 | 690,609,562.19 | 603,234,042.51 | 500,029,088.96 |
| 应付票据及应付账款 | 171,509,517.01 | 127,585,975.89 | 146,138,277.44 | 147,900,728.46 |
| 其中：应付票据 | 48,730,879.81 | 26,555,207.57 | 24,552,843.1 | 29,905,941.18 |
| 应付账款 | 122,778,637.2 | 101,030,768.32 | 121,585,434.34 | 117,994,787.28 |
| 预收款项 | 10,561 | 69,276.71 | 69,276.71 | 32,023.26 |
| 合同负债 | 146,449,966.56 | 116,340,704.09 | 106,821,060.04 | 97,362,245.28 |
| 应付职工薪酬 | 32,027,450.6 | 28,096,072.88 | 42,922,789.1 | 33,970,592.23 |
| 应交税费 | 15,055,501.52 | 8,825,827.34 | 3,693,979.93 | 10,368,247.96 |
| 其他应付款合计 | 316,228,434.7 | 291,941,690.94 | 276,659,075.24 | 287,266,827.98 |
| 一年内到期的非流动负债 | - | - | - | 376,260 |
| 其他流动负债 | 2,045,230.67 | 1,302,109.61 | 1,351,505.04 | 1,624,562.42 |
| 流动负债合计 | 1,390,514,705.95 | 1,264,771,219.65 | 1,180,890,006.01 | 1,078,930,576.55 |
| 非流动负债: | | | | |
| 递延收益 | 91,878,130.66 | 89,980,108.02 | 84,454,271.85 | 73,221,769.01 |
| 递延所得税负债 | 3,821,414.96 | 4,532,220.1 | 7,209,344.1 | 3,106,980.83 |
| 非流动负债合计 | 95,699,545.62 | 94,512,328.12 | 91,663,615.95 | 76,328,749.84 |
| 负债合计 | 1,486,214,251.57 | 1,359,283,547.77 | 1,272,553,621.96 | 1,155,259,326.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 625,900,859 | 423,600,000 | 423,600,000 | 423,600,000 |
| 资本公积 | 2,285,645,719.79 | 2,488,586,578.79 | 2,488,586,578.79 | 2,487,295,700.22 |
| 减:库存股 | 30,020,576.71 | 30,020,576.71 | 30,020,576.71 | 30,020,576.71 |
| 其他综合收益 | -11,707,392.86 | -9,575,782.23 | -10,198,764.41 | -10,353,271.02 |
| 盈余公积 | 156,644,590.06 | 156,644,590.06 | 156,644,590.06 | 152,803,980.38 |
| 未分配利润 | 703,480,828.03 | 751,453,419.26 | 729,584,279.73 | 707,581,720.17 |
| 归属于母公司股东权益合计 | 3,729,944,027.31 | 3,780,688,229.17 | 3,758,196,107.46 | 3,730,907,553.04 |
| 少数股东权益 | -11,834,969.35 | -11,399,453.87 | -11,250,301.48 | -9,929,228.79 |
| 股东权益合计 | 3,718,109,057.96 | 3,769,288,775.3 | 3,746,945,805.98 | 3,720,978,324.25 |
| 负债和股东权益合计 | 5,204,323,309.53 | 5,128,572,323.07 | 5,019,499,427.94 | 4,876,237,650.64 |
| 公告日期 | 2026-08-22 | 2026-04-25 | 2026-04-25 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |